<DOC>
	<DOC>NCT01580644</DOC>
	<brief_summary>The purpose of this study is to evaluate the amount of GLPG0187 present in the blood (pharmacokinetics) after a single oral dose of the prodrug of GLPG0187 given to healthy subjects. Two formulations of the GLPG0187 prodrug will be compared, as well as the effect of food and dose proportionality of the best formulation. Furthermore, during the course of the study, safety and tolerability will be characterized.</brief_summary>
	<brief_title>Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male, age 1850 years BMI between 1830 kg/m2 Any condition that might interfere with the procedures or tests in this study Drug or alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>